Healthcare
Wednesday, June 22, 2016
BRIEF-Epizyme initiates collaboration on combination trial of tazemetostat and tecentriq for treatment of Non-Hodgkin Lymphoma
* Epizyme initiates collaboration on combination trial of
tazemetostat and tecentriq(tm)(atezolizumab) for treatment of
Non-Hodgkin Lymphoma
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment